RIGL ææ°ååæã®æ±ºç®å ±åæž
çºè¡šæ¥8/4/2026
EPSå®çžŸïŒUSDïŒ0.93
売äžé«å®çžŸïŒUSDïŒ78.70M
Rigel Pharmaceuticals Incã®æ±ºç®æ¥ã»å ±åæž
ãã®ããŒãžã§ã¯ãææ°ã® Rigel Pharmaceuticals Inc ã®æ±ºç®å ±åæžã次å Rigel Pharmaceuticals Inc ã®æ±ºç®äºå®æ¥ãéå»ã®ããŒã¿ãRigel Pharmaceuticals Inc ã®æ±ºç®é»è©±äŒè°ãã¥ãŒã¹ãªã©ã詳现㪠Rigel Pharmaceuticals Inc ã®æ±ºç®ããŒã¿ãæäŸããŠããŸãã
RIGL 次åååæã®æ±ºç®çºè¡šæ¥
çºè¡šæ¥--
EPSäºæ³ïŒUSDïŒ--
売äžé«äºæ³ïŒUSDïŒ--
RIGL FY2025 決ç®
EPS (å幎åææ¯)20.401951.47%
売äžé« (å幎åææ¯)294.28M64.15%
Rigel Pharmaceuticals IncïŒRIGLïŒã®æ±ºç®å±¥æŽ
| å ¬éæ¥ | 察象æéçµäº | EPS/äºæž¬ | åç/äºæž¬ | EPSãµãã©ã€ãº % | 売äžé«ãµãã©ã€ãº % |
|---|---|---|---|---|---|
| 8/4/2026 | 06/2026 | 0.93/0.62 | 78.70M/69.46M | 50.41% | 13.30% |
| 5/5/2026 | 03/2026 | 0.47/0.76 | 58.82M/64.22M | -38.16% | -8.40% |
| 3/3/2026 | 12/2025 | 14.72/1.25 | 69.80M/68.70M | 1080.60% | 1.60% |
| 11/4/2025 | 09/2025 | 1.55/0.85 | 69.46M/61.88M | 80.96% | 12.25% |
| 8/5/2025 | 06/2025 | 3.33/2.58 | 101.69M/88.95M | 29.19% | 14.32% |
| 5/6/2025 | 03/2025 | 0.64/0.09 | 53.33M/43.87M | 620.56% | 21.56% |
| 3/4/2025 | 12/2024 | 0.81/0.47 | 57.60M/51.73M | 74.01% | 11.34% |
| 11/7/2024 | 09/2024 | 0.71/0.06 | 55.31M/41.93M | 1109.91% | 31.91% |